Segueix
Robert Edfors
Robert Edfors
MD, PhD, FESC
Correu electrònic verificat a ki.se - Pàgina d'inici
Títol
Citada per
Citada per
Any
Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation
JJ Carrero, M Evans, K Szummer, J Spaak, L Lindhagen, R Edfors, ...
Jama 311 (9), 919-928, 2014
1772014
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction
M Evans, JJ Carrero, K Szummer, A Åkerblom, R Edfors, J Spaak, ...
Journal of the American College of Cardiology 67 (14), 1687-1697, 2016
652016
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non–ST-segment elevation myocardial infarction
K Szummer, J Oldgren, L Lindhagen, JJ Carrero, M Evans, J Spaak, ...
Jama 313 (7), 707-716, 2015
562015
A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab …
C Lewinter, TH Nielsen, LR Edfors, C Linde, JM Bland, M LeWinter, ...
European heart journal 43 (27), 2562-2569, 2022
482022
Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function
R Edfors, A Sahlén, K Szummer, H Renlund, M Evans, JJ Carrero, ...
Heart 104 (19), 1575-1582, 2018
352018
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
M Blöndal, T Ainla, J Eha, P Lõiveke, T Marandi, A Saar, G Veldre, ...
European Heart Journal-Quality of Care and Clinical Outcomes 8 (3), 307-314, 2022
242022
Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction …
T Hellgren, M Blöndal, J Jortveit, T Ferenci, J Faxén, C Lewinter, J Eha, ...
European Heart Journal Open 2 (4), oeac042, 2022
142022
Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real …
R Edfors, T Jernberg, C Lewinter, M Blöndal, J Eha, P Lõiveke, T Marandi, ...
European Heart Journal-Quality of Care and Clinical Outcomes 8 (4), 429-436, 2022
102022
Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction
R Edfors, L Lindhagen, J Spaak, M Evans, P Andell, T Baron, J Mörtberg, ...
Journal of Internal Medicine 288 (5), 581-592, 2020
82020
Renal function is associated with long-term outcomes independent of degree of atherosclerosis: 6-year data from the Swedish Coronary Angiography and Angioplasty Registry
R Edfors, K Szummer, M Evans, JJ Carrero, J Spaak, S James, ...
European Heart Journal–Quality of Care and Clinical Outcomes 2 (2), 91-98, 2016
82016
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial
HJL Heerspink, AL Birkenfeld, DZI Cherney, HM Colhoun, L Ji, C Mathieu, ...
Diabetes research and clinical practice 204, 110908, 2023
72023
Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction in relation to renal function: 1-year SWEDEHEART registry data
R Edfors, AS Sahlen, KS Szummer, HR Renlund, ME Evans, JJ Carrero, ...
EUROPEAN HEART JOURNAL 38, 1263-1263, 2017
52017
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
J Mörtberg, B Salzinger, K Lundwall, R Edfors, SH Jacobson, HN Wallén, ...
International Journal of Cardiology 373, 64-71, 2023
42023
SWEDEHEART-1-year data show no benefit of newer generation drug-eluting stents over bare-metal stents in patients with severe kidney dysfunction following percutaneous coronary …
R Edfors, S James, K Szummer, M Evans, JJ Carrero, J Faxén, J Persson, ...
Coronary Artery Disease 31 (1), 49-58, 2020
32020
6011 Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction in relation to renal function: 1-year SWEDEHEART registry data
R Edfors, AS Sahlen, KS Szummer, HR Renlund, ME Evans, JJ Carrero, ...
European heart journal 38 (suppl_1), ehx493. 6011, 2017
22017
P3120 Prevention of heart failure in treatments with trastuzumab and anthracyclines: a meta-analysis
C Lewinter, LR Edfors, TH Nielsen, E Hedayati, L Kober, F Braunschweig, ...
European Heart Journal 40 (Supplement_1), ehz745. 0195, 2019
12019
Comparison of enoxaparin versus fondaparinux in non-ST-elevation myocardial infarction: a real world analysis of 44.813 patients in the SWEDEHEART registry
K Szummer, L Lindhagen, JJ Carrero, M Evans, JJ Spaak, R Edfors, ...
European Heart Journal 35, 696-696, 2014
12014
A case of tularemia in a Danish hunter
R Edfors, B Smith, T Lillebaek
Ugeskrift for Laeger 172 (5), 381-382, 2010
12010
Gender differences in characteristics, treatment and outcomes in ST elevation myocardial infarction patients in four European countries
T Hellgren, M Blondal, T Ainla, J Jortveit, J Eha, P Loiveke, T Marandi, ...
European Heart Journal 42 (Supplement_1), ehab724. 1114, 2021
2021
DOAC versus warfarin in patients with atrial fibrillation and stage IV-V chronic kideny disease including patients on dialysis
A Wartanian, C Lewinter, R Edfors
European Heart Journal 42 (Supplement_1), ehab724. 0551, 2021
2021
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20